JP Morgan Chase
SYNH

JP Morgan Chase’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

JP Morgan Chase’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-14,100
Closed -$730K – 6088
2019
Q1 		$730K Buy
+14,100
New +$684K ﹤0.01% 3987

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
CFB
Cullen/Frost Bankers San Antonio, Texas $10.1B AUM 29.18% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

JP Morgan Chase's SYNH Position: Q3 2023 in Review

JP Morgan Chase sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 554,483 shares — an estimated $23.4M sold.

JP Morgan Chase first reported a position in SYNH in Q4 2014 and held it in 32 quarters. The position peaked at $228M in Q4 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • JP Morgan Chase reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • JP Morgan Chase sold 554,483 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $23.4M.
  • JP Morgan Chase first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2014 and held it in 32 quarters.
  • JP Morgan Chase's Syneos Health, Inc. Class A Common Stock position peaked at $228M in Q4 2021.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on JP Morgan Chase's 13F filing for Q3 2023, filed 14 Nov 2023.